Literature DB >> 31954658

High-Resolution Late Gadolinium Enhancement Magnetic Resonance for the Diagnosis of Myocardial Infarction With Nonobstructed Coronary Arteries.

Pierre-Francois Lintingre1, Hubert Nivet1, Stéphanie Clément-Guinaudeau1, Claudia Camaioni1, Soumaya Sridi1, Olivier Corneloup1, Edouard Gerbaud2, Pierre Coste2, Gael Dournes1, Valérie Latrabe1, Francois Laurent3, Michel Montaudon3, Hubert Cochet4.   

Abstract

OBJECTIVES: The aim of this study was to assess the diagnostic yield of cardiac magnetic resonance (CMR) including high-resolution (HR) late gadolinium enhancement (LGE) imaging using a 3-dimensional respiratory-navigated method in patients with myocardial infarction with nonobstructed coronary arteries (MINOCA).
BACKGROUND: CMR plays a pivotal role for the diagnosis of patients with MINOCA. However, the diagnosis remains inconclusive in a significant number of patients, the results of CMR being either negative or uncertain (i.e., compatible with multiple diagnoses).
METHODS: Consecutive patients categorized as having MINOCA after blood testing, electrocardiography, coronary angiography, and echocardiography underwent conventional CMR, including cine, T2-weighted, first-pass perfusion, and conventional breath-held LGE imaging. HR LGE imaging using a free-breathing method allowing improved spatial resolution (voxel size 1.25 × 1.25 × 2.5 mm) was added to the protocol when the results of conventional CMR were inconclusive and was optional otherwise. Diagnoses retained after reviewing conventional CMR were compared with those retained after the addition of HR LGE imaging.
RESULTS: From 2013 to 2016, 229 patients were included (mean age 56 ± 17 years, 45% women). HR LGE imaging was performed in 172 patients (75%). In this subpopulation, definite diagnoses were retained after conventional CMR in 86 patients (50%): infarction in 39 (23%), myocarditis in 32 (19%), takotsubo cardiomyopathy in 13 (8%), and other diagnoses in 2 (1%). In the remaining 86 patients (50%), results of CMR were inconclusive: negative in 54 (31%) and consistent with multiple diagnoses in 32 (19%). HR LGE imaging led to changes in final diagnosis in 45 patients (26%) and to a lower rate of inconclusive final diagnosis (29%) (p < 0.001). In particular, HR LGE imaging could reveal or ascertain the diagnosis of infarction in 14% and rule out the diagnosis of infarction in 12%. HR LGE imaging was particularly useful when the results of transthoracic echocardiography, ventriculography, and conventional CMR were negative, with a 48% rate of modified diagnosis in this subpopulation.
CONCLUSIONS: HR LGE imaging has high diagnostic value in patients with MINOCA and inconclusive findings on conventional CMR. This has major diagnostic, prognostic, and therapeutic implications.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiac magnetic resonance; late gadolinium enhancement; myocardial infarction with nonobstructed coronary arteries

Year:  2020        PMID: 31954658     DOI: 10.1016/j.jcmg.2019.11.020

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  11 in total

Review 1.  Data integration for the numerical simulation of cardiac electrophysiology.

Authors:  Stefano Pagani; Luca Dede'; Andrea Manzoni; Alfio Quarteroni
Journal:  Pacing Clin Electrophysiol       Date:  2021-03-08       Impact factor: 1.976

Review 2.  Contemporary Cardiovascular Imaging Advancements and Social Media.

Authors:  Pedro Covas; Haneen Ismail; Joseph Krepp; Brian G Choi; Jannet F Lewis; Richard J Katz; Andrew D Choi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-03-15

3.  What Is of Recent Interest in Cardiac Imaging?: Insights From the JACC Family of Journals.

Authors:  Leslee J Shaw; Y Chandrashekhar
Journal:  J Am Coll Cardiol       Date:  2021-12-07       Impact factor: 24.094

4.  Prognosis in patients with coronary heart disease and breath-holding limitations: a free-breathing cardiac magnetic resonance protocol at 3.0 T.

Authors:  Keyan Wang; Wenbo Zhang; Shuman Li; Xiaoming Bi; Michaela Schmidt; Jing An; Jie Zheng; Jingliang Cheng
Journal:  BMC Cardiovasc Disord       Date:  2021-12-07       Impact factor: 2.298

Review 5.  Artificial Intelligence-A Good Assistant to Multi-Modality Imaging in Managing Acute Coronary Syndrome.

Authors:  Ming-Hao Liu; Chen Zhao; Shengfang Wang; Haibo Jia; Bo Yu
Journal:  Front Cardiovasc Med       Date:  2022-02-16

6.  Imaging of Clinically Unrecognized Myocardial Fibrosis in Patients With Suspected Coronary Artery Disease.

Authors:  Panagiotis Antiochos; Yin Ge; Kevin Steel; Scott Bingham; Shuaib Abdullah; J Ronald Mikolich; Andrew E Arai; W Patricia Bandettini; Amit R Patel; Afshin Farzaneh-Far; John F Heitner; Chetan Shenoy; Steve W Leung; Jorge A Gonzalez; Dipan J Shah; Subha V Raman; Victor A Ferrari; Jeanette Schulz-Menger; Matthias Stuber; Orlando P Simonetti; Raymond Y Kwong
Journal:  J Am Coll Cardiol       Date:  2020-08-25       Impact factor: 24.094

Review 7.  Whole-Heart High-Resolution Late Gadolinium Enhancement: Techniques and Clinical Applications.

Authors:  Solenn Toupin; Théo Pezel; Aurélien Bustin; Hubert Cochet
Journal:  J Magn Reson Imaging       Date:  2021-06-21       Impact factor: 5.119

8.  Distinct non-ischemic myocardial late gadolinium enhancement lesions in patients with type 2 diabetes.

Authors:  Annemie Stege Bojer; Martin Heyn Sørensen; Niels Vejlstrup; Jens P Goetze; Peter Gæde; Per Lav Madsen
Journal:  Cardiovasc Diabetol       Date:  2020-10-22       Impact factor: 9.951

9.  A valuable cardiac magnetic resonance investigation after MINOCA/takotsubo Syndrome: a case report.

Authors:  Snehasis Pradhan; Nedall Zalloum; Gresa Kciku; Hans-Joachim Trappe
Journal:  ESC Heart Fail       Date:  2020-09-23

Review 10.  The Role of Cardiac Magnetic Resonance in Myocardial Infarction and Non-obstructive Coronary Arteries.

Authors:  Kate Liang; Eleni Nakou; Marco Giuseppe Del Buono; Rocco Antonio Montone; Domenico D'Amario; Chiara Bucciarelli-Ducci
Journal:  Front Cardiovasc Med       Date:  2022-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.